The University of Toronto (UofT) and Astellas Pharma Canada Inc. (Astellas) have jointly established the Astellas Prostate Cancer Innovation Fund at the University of Toronto, with the purpose of supporting and advancing prostate cancer research. Under the direction and supervision of an interdisciplinary UofT review committee, overseen by the Chair of the Division of Urology, the Fund will provide 3 grants in the amount of $50,000. Grants are open to faculty members in the Faculty of Medicine and across UofT’s affiliated hospitals and research institutes, with academic appointment to the following Departments:
- Surgery
- Medicine
- Laboratory Medicine & Pathobiology
- Radiation Oncology
- Medical Imaging
View attachments for complete details and to apply: